Track topics on Twitter Track topics that are important to you
FDA-approved labeling includes boxed warning for depression and suicidality, though this is specific for Huntington's disease patients, who are prone...
CD33 inhibiting drug that was yanked from the market in 2010 due to reports of veno-occlusive disease is now fully...
This week's roundup includes Almirall's appointment of a former Sanofi employee as CEO and various other high-level appointments by Axial...
Chinese start-up CARsgen Therapeutics hopes to launch trials in the US for its first-in-class anti-claudin18.2 CAR-T cell therapy. It is...
Theranexus, annonce la délivrance du brevet américain n° US 9,750,734 sur lequel l’entreprise jouit d’une licence exclusive en accord avec le CEA. Intitulé « Use of Flecainide as an anti-con...
Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances Joël Richard, Vice-Président Senior Développement Peptides du groupe Ipsen, spécialiste inter...
DelveInsight's, NarcolepsyPipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding f...
We have published hundreds of Theranexus news stories on BioPortfolio along with dozens of Theranexus Clinical Trials and PubMed Articles about Theranexus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theranexus Companies in our database. You can also find out about relevant Theranexus Drugs and Medications on this site too.